Talk:Dextromethorphan/bupropion
This is the talk page for discussing improvements to the Dextromethorphan/bupropion article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Dextromethorphan/bupropion.
|
Appropriate tag? edit
The bulk of this article relies on one source-- [1], the Auvelity Prescribing Information published by the manufacturer. It's cited over 30 times... The Prescribing Information itself is mostly just a summary of 2 clinical trials, GEMINI [4] and another referenced as ASCEND in [5]. Between those two trials, roughly ~200 patient reactions to DXM/BUP have been studied.
Given the small sample size and the lack of studies by groups aside from the manufacturer, I think it's appropriate to tag this as needing additional citations/sources (as other researchers have time to study the drug). Do other people agree?
If so, which tag would fit best? I wasn't sure whether {{more citations needed}}, {{More medical citations needed}}, or {{more science citations needed}} would be most appropriate. NeuroPanda (talk) 16:14, 7 September 2022 (UTC)